title: TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing.
abstract: OBJECTIVE
  To evaluate the expression of transforming growth factor beta1 (TGF-beta1) and fibroblast growth factor 2 (FGF-2) mRNA in stromal cells in response to injury in the presence of either TGF-beta1 or FGF-2. It has been shown previously that heparan sulfate proteoglycans and FGF-2 are present transiently during wound repair in vivo and that an increase in TGF-beta1 mRNA is detected rapidly after injury.
  
  
  METHODS
  Primary corneal fibroblasts were cultured to confluency, serum starved, and linear wound(s) were made in medium containing TGF-beta1 or FGF-2. TGF-beta1 and FGF-2 mRNA expression were evaluated using both northern blot analysis and in situ hybridisation. Both dose dependent and time course experiments were performed. Whole eye organ culture experiments were also carried out and growth factor expression was assessed.
  
  
  RESULTS
  Injury and exogenous TGF-beta1 increased TGF-beta1 mRNA values. The increase in expression of FGF-2 mRNA was not detected until wound closure. In contrast, FGF-2 inhibited the expression of TGF-beta1. TGF-beta1 increased TGF-beta1 mRNA stability but did not alter that of FGF-2. Migration assay data demonstrated that unstimulated stromal cells could be activated to migrate to specific growth factors.
  
  
  CONCLUSIONS
  TGF-beta1 specifically enhances cellular responsiveness, as shown by increased stability after injury and the acquisition of a migratory phenotype. These data suggest that there is an integral relation during wound repair between TGF-beta1 and FGF-2.
authors.affiliation: Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
authors.forename: Q H
authors.initials: QH
authors.lastname: Song
authors.forename: V E
authors.initials: VE
authors.lastname: Klepeis
authors.forename: M A
authors.initials: MA
authors.lastname: Nugent
authors.forename: V
authors.initials: V
authors.lastname: Trinkaus-Randall
mesh_terms: D015152:Blotting, Northern; D018929:Cell Culture Techniques; D002465:Cell Movement / Q000187:drug effects; D003315:Cornea / Q000473:pathology; D065306:Corneal Injuries; D004305:Dose-Response Relationship, Drug; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis* / Q000235:genetics; D005347:Fibroblasts / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000502:physiology*; D017403:In Situ Hybridization; D009924:Organ Culture Techniques; D012333:RNA, Messenger / Q000235:genetics; D017154:Stromal Cells / Q000473:pathology; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D053773:Transforming Growth Factor beta1; D014945:Wound Healing / Q000502:physiology*
chemical_list: D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D016222:Fibroblast Growth Factor 2